Company intelligence / Profile preview

Marlborough Street Partners

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Marlborough Street Partners is a strategic advisory firm based in Boston, Massachusetts, that serves the global life sciences and biotechnology industries. The firm provides high-level consultancy to executive teams and boards of directors, focusing on corporate strategy, business development, and governance. Founded by James Geraghty, a former senior executive at Genzyme, the firm leverages extensive experience in the orphan drug and rare disease sectors. Marlborough Street Partners also engages in investment activities and provides guidance on navigating complex regulatory and commercial landscapes for emerging biotech companies.

Industry: Consulting

Beyond the preview

Go deeper on Marlborough Street Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marlborough Street Partners.

Explore the full profile